Home » Topics » Regulatory

Regulatory
RSS

Ocera obtains CE Mark for Zysa

May 21, 2012

First drug approved in E.U. for multiply relapsed/refractory aggressive NHL

May 11, 2012

FDA approves expanded dose range for schizophrenia drug

May 7, 2012

FDA approves Levaquin for new indication

May 4, 2012

FDA approves new therapy for type 1 Gaucher's disease

May 2, 2012

Afinitor approved in U.S. for new indication

April 30, 2012

FDA approves sNDA for Votrient

April 30, 2012

First medicine approved in E.U. for Cushing's disease

April 25, 2012

Alimera announces first marketing authorization for Iluvien in E.U.

April 25, 2012

Novartis seeking approval in Japan of Glivec for new indication

April 17, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for July 2, 2025.
Researchers arm CAR T cells to fight solid tumors
BioWorld
Aussie researchers have used CRISPR gene editing tools to “armor” chimeric antigen receptor (CAR) T cells to activate additional cancer-fighting proteins at the...
Bioversys, Shionogi in CHF529M lung infection collaboration
BioWorld Science
Antibiotics specialist Bioversys AG has sealed a potential CHF529 million (US$667.5 million) deal with Shionogi Co. Ltd., in which they will work together on...
Medtronic receives CE mark for its Vitalflow ECMO system
BioWorld MedTech
Medtronic plc received a CE mark for its Vitalflow extracorporeal membrane oxygenation (ECMO) system, which provides temporary support for the heart and lungs in...